Treatment of Alcohol Problems in the Elderly

Status Completed

Clinical Trial Summary

With the aging of western societies in the coming years combined with increasing alcohol consumption among elderly, the number of elderly with alcohol problems is expected to rise considerably. Elderly patients are often lonely; suffer from feelings of loss, fear to be a burden on their children and on society, and feel powerless. On the surface their alcohol related problems seem less severe that those of the middle-aged patients while in reality co-morbidity and social issues complicate alcohol dependency. Currently, no specific treatment tailored for alcohol use disorder among elderly is available. Consequently they receive either no treatment, are given brief advising from the general practitioner or are referred to treatment at specialized treatment institutions with no specific treatment for elderly. The investigators propose a study aimed at developing and testing an outpatient behavior therapy program for alcohol use disorders for seniors (60 years and older), which - if effective - can be easily implemented in routine care. Three centers from Denmark, Germany and USA (New Mexico) will participate. All three centers have a long and extensive experience with alcohol treatment and alcohol research. Patients fulfilling the DSM 5 criteria for alcohol use disorder are eligible for the study. After informed consent participants will be randomly assigned to either Motivational Enhancement Therapy (MET), four sessions/one session per week or MET followed by Community Re-enforcement Approach (CRA), eight sessions/one session per week - thus 12 weeks of treatment in total. 50% will receive MET and 50% MET+CRA. Primary outcome is percentage of patients with abstinence or controlled use (alcohol intake of equivalent blood alcohol content equal to or less than 0.5‰.). A total of 1000 patients will be enrolled. Participants will be assessed with a battery of international validated instruments measuring drinking pattern as well as key elements of treatment. Participants are assessed before initiation of treatment, at the end of MET treatment (four weeks), at the end of MET+CRA treatment (12 weeks), at 6 months, and at 12 months.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02084173
Study type	Interventional
Source	University of Southern Denmark
Contact
Status	Completed
Phase	N/A
Start date	January 2014
Completion date	October 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02179749` - Mifepristone Treatment of Alcohol Use Disorder	Phase 2
Completed	`NCT02113618` - Effect of Cognitive Training on Alcohol Use Outcomes	N/A
Completed	`NCT01008280` - Baclofen to Reduce Alcohol Use in Veterans With HCV	Phase 4
Active, not recruiting	`NCT02671019` - Effectiveness and Costs of Internet-based Treatment for Harmful Alcohol Use and Face-to-face Treatment in Addiction Care	N/A
Completed	`NCT01751035` - Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD	N/A
Active, not recruiting	`NCT03695653` - Messaging Interventions to Reduce Alcohol Problems Project	N/A
Completed	`NCT02298751` - Exposure Therapy as Aftercare for Alcohol Use Disorder	N/A
Completed	`NCT01642381` - Component Analysis for Motivational Interviewing	N/A
Terminated	`NCT01566370` - Zonisamide for Heavy Drinkers With Bipolar Disorder	Phase 2
Completed	`NCT02384278` - Internet Based Cognitive Behavior Treatment for Alcohol Problems	N/A
Completed	`NCT02511808` - Adaptive Interventions for Problem Drinkers	N/A
Completed	`NCT01613014` - ABT-436 for Alcohol Dependence	Phase 2
Completed	`NCT02905162` - Understanding Longitudinal Clinical Outcomes and Post-release Retention in Care Among HIV-infected Prisoners in Lusaka, Zambia
Completed	`NCT02808468` - Brief Restructuring Intervention Following Trauma Exposure	N/A
Completed	`NCT01692054` - Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication	N/A
Completed	`NCT02500602` - CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders	Phase 2
Active, not recruiting	`NCT02713217` - Implementing a Blended Care Model That Integrates Mental Healthcare and Primary Care Using Telemedicine and Care Management for Patients With Depression or Alcohol Use Disorder in Small Primary Care Clinics
Recruiting	`NCT02465177` - Tailoring Screening, Brief Intervention, and Referral to Treatment for Medical ICU Survivors
Completed	`NCT02193256` - Varenicline + Prazosin for Heavy Drinking Smokers	Early Phase 1
Completed	`NCT01172210` - Examining Common Substrates of Eating and Alcohol Use Disorders	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.